Invention Grant
- Patent Title: Humanized or chimeric CD3 antibodies
-
Application No.: US15744317Application Date: 2016-07-14
-
Publication No.: US11359015B2Publication Date: 2022-06-14
- Inventor: Rik Rademaker , Isil Altintas , Patrick Engelberts , Janine Schuurman , Paul Parren
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: DKPA201500413 20150715,DKPA201500414 20150715,DKPA201500416 20150716,EPPCT/EP2016/050296 20160108
- International Application: PCT/EP2016/066845 WO 20160714
- International Announcement: WO2017/009442 WO 20170119
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/28 ; C07K16/32 ; A61K39/00
Abstract:
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
Public/Granted literature
- US20190284278A1 HUMANIZED OR CHIMERIC CD3 ANTIBODIES Public/Granted day:2019-09-19
Information query
